PepGen (PEPG) Stock Chart & Stock Price History → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free PEPG Stock Alerts $13.34 -0.36 (-2.63%) (As of 05/9/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media PepGen Stock Price Performance5 Day Performance-6.06%1 Month Performance+9.88%3 Month Performance-9.00%6 Month Performance+227.76%Year-To-Date Performance+96.18%1 Year Performance-10.23% Receive PEPG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PepGen and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. PEPG Stock Chart for Thursday, May, 9, 2024 PEPG Chart by TradingView PepGen Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$13.96$13.70-1.86%$14.15$13.6024,314 shs$443.74 million05/07/2024$13.95$13.96+0.07%$14.44$13.6838,347 shs$452.16 million05/06/2024$14.20$13.95-1.76%$14.64$13.6443,478 shs$451.84 million05/03/2024$14.49$14.20-2.00%$15.22$13.95106,238 shs$459.94 million05/02/2024$13.90$14.49+4.24%$14.59$13.41160,724 shs$469.33 million05/01/2024$12.28$13.90+13.19%$13.94$12.10146,559 shs$450.22 million Get the Latest News and Ratings for PEPG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PepGen and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$11.68$12.28+5.14%$12.71$11.7736,335 shs$397.26 million04/29/2024$11.93$11.68-2.10%$12.79$11.5974,586 shs$377.85 million04/26/2024$11.70$11.93+1.97%$12.09$11.2638,359 shs$385.94 million04/25/2024$11.83$11.70-1.10%$11.92$10.8535,240 shs$378.50 million04/24/2024$11.72$11.83+0.94%$11.97$11.2920,088 shs$382.70 million04/23/2024$11.39$11.72+2.90%$11.80$11.3814,316 shs$379.19 million04/22/2024$10.54$11.39+8.12%$11.44$10.2269,409 shs$368.47 million04/19/2024$11.85$10.53-11.10%$12.25$10.39117,940 shs$340.65 million04/18/2024$11.50$11.85+3.00%$12.13$11.0847,171 shs$372.07 million04/17/2024$12.59$11.50-8.66%$12.61$11.2080,986 shs$372.03 million04/16/2024$12.23$12.59+2.94%$12.88$12.0245,976 shs$407.29 million04/15/2024$13.00$12.23-5.92%$13.21$11.9944,110 shs$395.64 million04/12/2024$12.71$13.00+2.28%$13.88$12.1138,932 shs$420.55 million04/11/2024$11.90$12.71+6.81%$12.87$11.7737,220 shs$411.17 million04/10/2024$12.14$11.90-1.98%$12.50$11.6834,797 shs$384.97 million04/09/2024$12.36$12.14-1.78%$12.89$11.4927,751 shs$392.78 million04/08/2024$11.89$12.36+3.95%$12.48$11.5138,365 shs$399.85 million04/05/2024$11.59$11.89+2.59%$11.91$11.3318,884 shs$384.64 million04/04/2024$10.87$11.59+6.62%$11.86$11.0157,979 shs$374.98 million04/03/2024$13.05$10.87-16.70%$13.44$10.78109,416 shs$351.64 million04/02/2024$14.48$13.05-9.88%$14.21$12.5769,685 shs$422.17 million04/01/2024$14.70$14.48-1.50%$15.34$14.23173,452 shs$468.43 million03/29/2024$14.70$14.70$14.90$14.0330,717 shs$475.60 million03/28/2024$14.09$14.70+4.33%$14.90$14.0030,717 shs$475.55 million03/27/2024$13.13$14.09+7.31%$14.18$13.1725,731 shs$455.81 million03/26/2024$13.29$13.13-1.20%$13.50$12.5722,083 shs$424.76 million03/25/2024$14.91$13.29-10.87%$14.99$12.58102,196 shs$429.93 million03/22/2024$14.79$14.91+0.81%$15.37$14.5341,232 shs$482.34 million03/21/2024$14.87$14.79-0.54%$15.25$14.2734,697 shs$478.46 million03/20/2024$13.97$14.87+6.44%$15.35$13.9861,046 shs$481.04 million03/19/2024$13.65$13.97+2.34%$14.74$13.5948,438 shs$441.63 million03/18/2024$15.44$13.65-11.59%$15.82$13.6183,880 shs$441.58 million03/15/2024$13.91$15.44+11.00%$16.14$13.77673,345 shs$367.63 million03/14/2024$13.75$13.91+1.16%$14.35$13.5068,732 shs$331.20 millionDems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE.03/13/2024$13.89$13.75-1.01%$14.86$13.3691,076 shs$327.39 million03/12/2024$14.13$13.89-1.70%$14.67$13.8740,867 shs$330.72 million03/11/2024$14.24$14.13-0.77%$14.92$14.0145,802 shs$336.44 million03/08/2024$14.18$14.24+0.42%$15.04$14.0776,277 shs$339.05 million03/07/2024$15.41$14.18-7.98%$15.28$11.71240,580 shs$337.63 million03/06/2024$16.63$15.41-7.34%$16.86$15.27168,790 shs$366.91 million03/05/2024$17.30$16.63-3.87%$17.51$16.6283,651 shs$396.03 million03/04/2024$16.62$17.30+4.09%$17.45$16.63185,175 shs$411.91 million03/01/2024$16.95$16.62-1.95%$17.41$16.21176,174 shs$395.72 million02/29/2024$14.78$16.95+14.68%$17.40$15.03185,200 shs$403.58 million02/28/2024$15.36$14.78-3.78%$15.65$14.55115,264 shs$351.91 million02/27/2024$14.53$15.36+5.71%$15.90$14.61168,133 shs$365.72 million02/26/2024$13.88$14.53+4.68%$14.58$13.8846,219 shs$345.96 million02/23/2024$13.95$13.88-0.50%$14.57$13.5699,957 shs$330.48 million02/22/2024$13.65$13.95+2.20%$14.32$13.56107,519 shs$332.15 million02/21/2024$13.78$13.65-0.94%$14.29$13.5269,819 shs$325.01 million02/20/2024$13.89$13.78-0.79%$14.39$13.4468,816 shs$328.16 million02/19/2024$13.89$13.89$14.60$13.6063,300 shs$330.72 million02/16/2024$14.11$13.89-1.56%$14.60$13.6063,359 shs$330.72 million02/15/2024$13.53$14.11+4.29%$14.25$13.7760,486 shs$336.02 million02/14/2024$13.01$13.53+4.00%$14.13$13.3760,785 shs$322.15 million02/13/2024$13.45$13.01-3.27%$13.58$12.6588,940 shs$309.77 million02/12/2024$14.66$13.45-8.25%$15.11$12.30232,907 shs$320.24 million02/09/2024$15.09$14.66-2.85%$15.14$14.5054,205 shs$349.06 million02/08/2024$12.51$15.09+20.62%$15.76$12.08443,088 shs$359.29 million Related Companies: Esperion Therapeutics Stock Price Chart Revance Therapeutics Stock Price Chart Acelyrin Stock Price Chart Theravance Biopharma Stock Price Chart Entrada Therapeutics Stock Price Chart Neurogene Stock Price Chart Lexicon Pharmaceuticals Stock Price Chart Fulcrum Therapeutics Stock Price Chart Korro Bio Stock Price Chart Heron Therapeutics Stock Price Chart Receive PEPG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PepGen and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PEPG) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaObama’s Forever Term [exposed]Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill Publishing348 million Americans lives to END as we know it?The Oxford ClubPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PepGen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.